StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Oppenheimer Reiterates Outperform Rating on Zimmer Biomet (ZBH)
October 30, 2024 4:28 PM
Oppenheimer analyst Steven Lichtman reiterated an Outperform rating and $135.00 price target on Zimmer Biomet (NYSE: ZBH).The analyst comments "3Q24 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Zimmer Biomet (ZBH) PT Raised to $117 at Truist Securities
October 31, 2024 12:37 PM
Form 10-Q ZIMMER BIOMET HOLDINGS, For: Sep 30
October 30, 2024 4:06 PM
Zimmer Biomet Holdings (ZBH) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY24 EPS Guidance
October 30, 2024 6:34 AM
Form 8-K ZIMMER BIOMET HOLDINGS, For: Oct 30
October 30, 2024 6:30 AM
Zimmer Biomet Announces Third Quarter 2024 Financial Results
October 30, 2024 6:30 AM
Zimmer Biomet Holdings (ZBH) to Debut New Z1 Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting
October 28, 2024 7:31 AM
Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting
October 28, 2024 7:30 AM
